Godin N J, Sachar D B, Winchester R, Simon C, Janowitz H D
Gut. 1984 Jul;25(7):743-7. doi: 10.1136/gut.25.7.743.
The proportions and absolute numbers of helper and suppressor T-cells in 40 patients with inflammatory bowel disease and 22 control subjects were determined, using the monoclonal antibodies OKT 4 and OKT 8. There were no significant differences in helper or suppressor cell proportions among 15 steroid treated patients with active inflammatory bowel disease, 10 patients with inactive inflammatory bowel disease, 10 patients with other gastrointestinal diseases, or 12 normal control subjects. In contrast, 15 patients with active inflammatory bowel disease not treated with corticosteroids manifested increased proportions of helper cells and decreased proportions of suppressor cells (p less than 0.001), compared with all other patient groups and to normal controls. When absolute numbers of helper and suppressor subsets were measured, these alterations in proportions of helper and suppressor cells were primarily attributable to decreased counts of suppressor T-cells both in patients with active Crohn's disease and in those with ulcerative colitis (p less than 0.01). In four patients undergoing serial study, the helper/suppressor ratios appeared to rise and fall respectively with clinical exacerbations and remissions of disease. These data provide additional evidence for the involvement of cellular immune systems in these disease processes.
采用单克隆抗体OKT 4和OKT 8测定了40例炎症性肠病患者和22例对照者体内辅助性T细胞和抑制性T细胞的比例及绝对数量。在15例接受类固醇治疗的活动性炎症性肠病患者、10例非活动性炎症性肠病患者、10例其他胃肠道疾病患者或12例正常对照者中,辅助性或抑制性细胞比例无显著差异。相比之下,与所有其他患者组及正常对照相比,15例未接受皮质类固醇治疗的活动性炎症性肠病患者表现出辅助性细胞比例增加,抑制性细胞比例降低(p<0.001)。当测定辅助性和抑制性亚群的绝对数量时,辅助性和抑制性细胞比例的这些改变主要归因于活动性克罗恩病患者和溃疡性结肠炎患者中抑制性T细胞数量的减少(p<0.01)。在4例接受系列研究的患者中,辅助性/抑制性比值似乎随着疾病的临床加重和缓解而分别升高和降低。这些数据为细胞免疫系统参与这些疾病过程提供了更多证据。